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Abstract
 
The initial interaction between B cells and follicular dendritic cells (FDCs) appears to be essen-
tial for germinal center (GC) formation. To identify molecules regulating this interaction, we
generated FDC-staining monoclonal antibodies (mAbs) and screened them for their ability to
block FDC-mediated costimulation of growth and differentiation of CD40-stimulated B cells.
Using one of the inhibitory mAbs, 8D6, we expression cloned the cDNA encoding the 8D6
antigen (Ag) from a human FDC line, HK. The 8D6 Ag is a novel protein of 282 amino acids
that is expressed abundantly on FDCs. Monolayers of COS cells transiently transfected with the
8D6 Ag cDNA stimulate B cell growth. The mAb 8D6 blocks the costimulatory function
completely. The inhibitory activity of the mAb 8D6 was demonstrated to be due to an inhibi-
tion of cell cycle progression of CD40 ligand–stimulated GC B cells. In addition, the mAb 8D6
inhibits the growth of a lymphoma of GC origin, L3055, which depends on FDCs or HK cells
for its growth. These findings suggest that the primary function of FDCs in the GC is to stim-
ulate B cell growth. An FDC signal molecule, 8D6 Ag, may be an important molecule to me-
diate this function.
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Introduction
 
The germinal center (GC) of the secondary lymphoid folli-
cles provides a microenvironment for B cells to undergo
clonal expansion and selection before differentiation into
memory B cells (1). The GC reaction is initiated by rapid
proliferation of Ag-stimulated B cells in association with
follicular dendritic cells (FDCs [2]). The mechanism for
this rapid growth is largely unknown. The GC B cells ex-
hibit features distinct from naive or memory B cells in that
they display a unique pattern of Ag expression on the cell
surface (3), undergo Ag receptor–mediated apoptosis (4),
and require essential survival signals from FDCs, as disrup-
tion of FDC–B cell clusters results in apoptosis of B cells (5,
 
6). This in vitro observation was confirmed
 
 
 
in vivo by
 
demonstrating in the lymphotoxin 
 
a
 
 knockout mice that
the initial interaction between FDCs and B cells is essential
for GC formation (7, 8). T cells expressing CD40 ligand
(CD40L) at the same time play a pivotal role in the GC re-
action, as evidenced in hyper-IgM patients and in mouse
models that have null mutations in the CD40 (9) or
CD40L genes (10). However, the signals for the survival,
proliferation, and differentiation of GC B cells are poorly
defined, partly because of the lack of a proper in vitro
model to analyze the cellular and molecular interactions
between B cells and FDCs.
To overcome the practical difficulty of isolating pure
FDCs and to mimic the GC reaction in vitro, we have es-
tablished an FDC line, HK, from human tonsils and used it
to determine molecular and cellular requirements for GC B
cell differentiation (11, 12). Using this in vitro model, we
have identified a key FDC-signaling molecule that stimu-
lates GC B cell proliferation.
 
Materials and Methods
 
Abs and Reagents. 
 
Abs used in this work were anti-CD40
(G28-5; American Type Culture Collection); DRC-1 (clone
R4/23; DAKO); 7D6 (a gift from Dr. Yong-Jun Liu, Laboratory
for Immunological Research, Schering-Plough Corp., Dardilly,
France); biotin-conjugated goat anti–mouse Ig or horseradish
peroxidase–conjugated goat anti–human IgG (BioSource Inter-
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national); streptavidin–biotinylated horseradish peroxidase com-
plex (Amersham Life Science); FITC-conjugated goat anti–
mouse IgG (PharMingen); and rabbit anti–human IgG or alkaline
phosphatase–conjugated rabbit
 
 
 
anti–mouse IgG (ICN Biomedi-
cals). Annexin V-FITC apoptosis detection kit was purchased
from Trevigen. Cytokines used in this work were CD40L
(Immunex Corp.), recombinant human (rh)IL-2 (Hoffman-La
Roche), rhIL-10 (R&D Systems), rhIL-4 (a gift from Schering-
Plough Corp.), and rhIL-6 (Sandoz Research Institute).
 
Cell Preparation and Cell Lines. 
 
Tonsillar B cells were pre-
pared and GC B cells were isolated by magnetic cell separation
(MACS; Miltenyi Biotec) as described previously (12). Fresh
FDC clusters were isolated from tonsils of 3–10-yr-old children
as described elsewhere (13). The FDC line, HK, was established
and maintained as described previously (11). The L3055 cell line
was a gift from Dr. Christopher D. Gregory (Institute of Cell Sig-
naling and School of Biomedical Sciences, University of Not-
tingham Medical School, Queen’s Medical Centre, Nottingham,
UK) and was cocultured with HK cells in IMDM (Irvine Scien-
tific) supplemented with 10% FCS (Life Technologies), 2 mM
glutamine, 100 U/ml penicillin G, and 100 
 
m
 
g/ml streptomycin
(Irvine Scientific).
 
Preparation of mAbs. 
 
Murine mAbs that react to human ton-
sillar FDCs were generated using a procedure that involved toler-
ization before immunization (14). Tolerization was achieved by
injection of newborn (within 40 h after birth) BALB/c mice with
tonsillar mononuclear cells (MNCs) containing human T and B
cells. At 2 mo of age, this animal was injected intraperitoneally
with freshly isolated FDC clusters (2 
 
3 
 
10
 
4
 
) three times in a 2-wk
interval. After the third immunization, the serum from the im-
munized mouse showed strong reactivity to tonsillar FDCs in
frozen tissue sections, but no reactivity to MNCs as assayed by
the cell-based ELISA. Spleen cells from this mouse were used as
fusion partners with a mouse myeloma cell line, SP 2/0, to gen-
erate mAbs. After the cell fusion, 
 
.
 
600 hybridomas were grown,
and their supernatants were screened for FDC staining as follows.
The hybridoma supernatants containing 
 
.
 
10 
 
m
 
g/ml of mouse Ig
were subjected to test their reactivities to MNCs by ELISA. The
hybridomas reacting to MNCs were discarded. The hybridomas
that were negative in MNC-based ELISA were subjected to the
next screening step: HK binding by ELISA and immunohis-
tochemical staining of the frozen sections of the tonsillar tissues.
These screening steps were repeated during a limiting dilution
procedure to select a single mAb-producing clone.
 
Immunohistological Staining. 
 
The adjacent cryostat sections of
a human tonsil were fixed in cold acetone. Slides were blocked
with 1% (wt/vol) BSA-PBS, then incubated with mAbs 8D6 or
DRC-1 followed by biotin-conjugated goat anti–mouse Ig and
streptavidin–biotinylated horseradish peroxidase complex. La-
beled peroxidase activity was revealed using DAB substrate
(Sigma Chemical Co.). Hematoxylin was used as counterstain.
For staining FDCs, cytospin preparations were fixed and blocked
as above. After incubation with mAb 8D6 or 7D6, the slides
were stained with FITC-conjugated goat anti–mouse Ig, then
observed under the fluorescence microscope.
 
Flow Cytometry. 
 
HK cells were released with trypsin and
EDTA. Single cell suspensions were stained with mAbs 8D6,
3C8, or mIgG1 followed by FITC-conjugated goat anti–mouse
Ig. Flow cytometric analysis was carried out on a FACScan™
(Becton Dickinson) with CELLQuest™ software (Becton Dick-
inson).
 
Expression Cloning of 8D6 Ag cDNA. 
 
The gene coding for
the 8D6 Ag was expression cloned as described previously
 
 
 
(15).
 
In brief, a cDNA expression library from HK cells (average insert
size 
 
z
 
2 kb) was electroporated into 
 
Escherichia coli 
 
DH10B, and
plasmid DNA was prepared from pools of transformants using
Wizard
 
®
 
 Maxiprep resin (Promega). DNA was transfected into
COS-1 cells (clone M6) using LipofectAMINE (GIBCO BRL)
according to the manufacturer’s instructions. Cells in 100-mm
plates were screened by in situ staining 48 h after transfection.
Monolayers were washed with PBS and fixed with methanol, fol-
lowed by a wash with binding buffer (1% [wt/vol] BSA and 0.2%
[wt/vol] sodium azide in PBS). Primary mAb (8D6 or mouse
IgG) was added at a final concentration of 5 
 
m
 
g/ml in binding
buffer for 90 min at 4
 
8
 
C. After washing again with binding
buffer, cells were stained with alkaline phosphatase (AP)-conju-
gated rabbit anti–mouse IgG (1:500 in binding buffer) for 45 min
at 4
 
8
 
C. Before developing, AP buffer (100 mM
 
 
 
Tris-HCl, pH
9.2, 100 mM
 
 
 
NaCl, 50 mM MgCl
 
2
 
, 0.1% [vol/vol] Tween 20, 1
mM levamisole) was added to block endogenous alkaline phos-
phatase at room temperature for 10 min. Alkaline phosphatase ac-
tivity was visualized with 0.33% (vol/vol) nitro blue tetrazolium
and 0.165% (vol/vol) 5-bromo-4-chloro-3-indolyl-phosphate
(Promega) in AP buffer. Once the signal had developed, the pos-
itive cells were scored by light microscopy.
 
Cultures of GC B Cells with HK Cells. 
 
GC B cells (10
 
6
 
 cells/
ml) were cocultured with irradiated HK cells (2 
 
3
 
 10
 
4
 
 cells per
well; 5,000 rads) in 24-well plates with or without mAb 8D6 (10
 
m
 
g/ml, if not indicated otherwise) in the presence of CD40L
(100 ng/ml), rIL-2 (10 U/ml), and rIL-10 (20 ng/ml) for 2 d,
washed, and then recultured (2 
 
3 
 
10
 
5
 
 cells/well) with irradiated
HK cells for another 4 d. Viable cells were counted by trypan
blue exclusive assay for proliferation. For differentiation, triplicate
culture supernatants were harvested and pooled, and IgG concen-
trations were measured by ELISA as described elsewhere (16).
For cell cycle analysis, GC B cells were labeled with carboxyfluo-
rescein diacetate succinimidyl ester (CFSE, 5 
 
m
 
M/ml in PBS;
Sigma Chemical Co.) at 4
 
8
 
C for 10 min. After culture as indi-
cated above, the CFSE intensity was analyzed by FACScan™.
 
Cultures of B Cells with COS Cells Expressing 8D6 Ag. 
 
COS
cells (2 
 
3 
 
10
 
5
 
/well) in 6-well plates were transfected with 2 
 
m
 
g
8D6 Ag cDNA and LipofectAMINE. After 24 h, transfected
COS cells were used for coculture with tonsillar B cells (10
 
6
 
/ml)
in the presence of anti-CD40 (100 ng/ml), rhIL-2 (10 U/ml),
rhIL-4 (50 U/ml), rhIL-6 (20 ng/ml), and rhIL-10 (20 ng/ml)
for 24 h. Activated B cells were removed from COS cells, recul-
tured in triplicate in 96-well plates in the presence of the above
cytokines, and subjected to proliferation (3 d) or differentiation
(10 d) assays as described above.
 
Results and Discussion
 
Generation of mAbs Staining FDCs. 
 
To identify FDC
molecules involved in the FDC–B cell interaction, a panel
of murine mAbs was raised against FDC clusters isolated
from human tonsils, and the mAbs were tested for their
ability to inhibit costimulation by FDCs of B cell growth
and differentiation. Mice were first tolerized neonatally with
human T and B cells, then immunized with FDC clusters to
obtain FDC-specific mAbs. 28 hybridomas were identified
that specifically stained the tonsillar GC. Of 28 hybridomas,
17 mAb clones were obtained by a limiting dilution
method. 16 IgG mAbs were purified from ascites by affinity
chromatography with protein A/G. One of these mAbs, an 
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IgG1 called 8D6, recognized a molecule expressed in hu-
man tonsillar GCs (Fig. 1, A and C) with an immunohis-
tochemical staining pattern similar to that of the known
FDC-specific mAb, DRC-1 (Fig. 1, B and D; reference
17). The mAb 8D6 staining was restricted to the follicles
(Fig. 1 C). There is a clear demarcation between the GC
and the T cell–rich area outside of the GC, which is nega-
tive for all three mAbs (e.g., DRC-1, 7D6, and 8D6). The
8D6 Ag is abundantly expressed in the GC, staining the re-
ticular network in the higher magnification (Fig. 1 A). The
diffuse staining pattern of mAb 8D6 in the GC is character-
istic of FDCs surrounding MNCs in the follicles. Such a
staining pattern was confirmed by the simultaneous staining
of the adjacent tissue sections with known FDC-specific
mAbs such as DRC-1 (Fig. 1 B; reference 17) and 7D6
(18). As it is virtually impossible to obtain a sufficient num-
ber of purified FDCs, without contamination with B cells,
for FACS
 
®
 
 analysis, a single cell suspension was prepared as
a cytospin. The cytospin preparations were stained with
FDC-staining mAbs and examined under the microscope.
At the single cell level, mAbs 8D6 (Fig. 1
 
 
 
E) and 7D6 (Fig.
1 F), another known FDC marker (18), both stained large,
cytoplasm-rich, sometimes binucleated FDCs. The isotype-
matched control Abs did not stain FDCs, excluding the pos-
sibility of autofluorescence.
 
Functional Blocking Activity of FDC-specific mAb 8D6 in
FDC–B Cell Interaction. 
 
To measure its ability to block
FDC–B cell interaction, mAb 8D6 was used in the cocul-
ture of B cells and FDC clusters. Because Ag-activated T
cells participate in GC reactions by direct cell-to-cell con-
tact and by secreting cytokines (19), we used the defined
signals of activated T cells, such as anti-CD40, IL-2, and IL-
10, to characterize mAb 8D6 functions. mAb 8D6 consis-
tently inhibited the FDC-mediated B cell IgG secretion
(Fig. 2 A). The blocking activity of mAb 8D6 is specific be-
cause another FDC-specific murine IgG1, mAb 3C8, did
not inhibit the FDC costimulatory activity (Fig. 2 A). mAb
3C8 was prepared by immunizing mice with HK cells, and
its Ag was abundantly expressed in FDC and HK cells (Fig.
1 H; reference 12). In addition to mAb 3C8, the other 13
IgG1, FDC-specific mAbs prepared in parallel with mAb
8D6 did not show blocking activity. Furthermore, five
other known human FDC-specific mAbs obtained by vari-
ous investigators, namely DRC-1, 7D6, HJ-2, GP93, and
Ki-M4 (17, 18, 20–22), did not inhibit the FDC costimula-
tory activity in our assay (data not shown).
A human FDC line, HK, resembles primary FDCs in its
ability to rescue GC B cells from apoptosis (11) and to sup-
port GC B cell growth and differentiation (12), suggesting
that HK cells and FDCs share common signaling molecules
for GC B cell differentiation. In the cocultures with HK
cells, GC B cell proliferation and differentiation supported
by HK cells were inhibited by the addition of mAb 8D6,
but not by the isotype control mAb 3C8 (Fig. 2 B). Such
inhibitory activity was also confirmed by demonstrating the
inhibition of the cell cycle progression of the CFSE-labeled
GC B cells after activation by soluble CD40L. When com-
pared with the control, GC B cells were observed in two-
fold excess (19 vs. 9%) in the first generation and 1.5-fold
(16 vs. 11%) in the second generation after HK cells were
treated with mAb 8D6 in the culture with CD40L, IL-2,
and IL-10 for 6 d (Fig. 2 C). This result suggests that inhibi-
tion by mAb 8D6 is due to the delay of B cell proliferation,
rather than to direct cell killing.
 
Expression Cloning of the 8D6 Ag cDNA. 
 
We used the
HK cell line to isolate the 8D6 Ag because of the difficulty
of obtaining a sufficient number of ex vivo FDCs to prepare
a cDNA library, and because HK expresses the 8D6 and
3C8 Ags (Fig. 1, G and H). The 8D6 Ag is expressed on the
HK cell membrane surface as well as in the intracellular
compartments. The cDNA encoding the 8D6 Ag was ex-
pression cloned in transfected COS cells using the HK cell
Figure 1. (A–F) Immunohis-
tological localization of 8D6 Ag
expression in human FDCs. The
serial cryostat sections from a
normal human tonsil (C and D)
or cytospin preparations of hu-
man tonsil FDC clusters (E and
F) were stained with mAbs 8D6
(A, C, and E), DRC-1 (B and
D), and 7D6 (F). A and B are
higher power views of boxed ar-
eas in C and D, respectively,
showing the network staining
pattern. Original magnifications:
(C and D) 3100; (E and F)
31,000. (G and H) 8D6 Ag ex-
pression on HK cells. HK cells
were stained with mAbs 8D6 (G,
filled histogram), 3C8 (H, filled
histogram), or isotype control
mouse IgG1 (G and H, open his-
tograms), followed by FITC-
conjugated goat anti–mouse
IgG. FITC intensity was ana-
lyzed by FACScan™. 
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cDNA library. The predicted amino acid sequence encoded
by this cDNA consists of 282 residues (Fig. 3 A). Hydropa-
thy analysis revealed a putative NH
 
2
 
-terminal signal se-
quence of 32 amino acids and a second hydrophobic region
close to the COOH terminus that was likely to be a trans-
membrane domain followed by a short intracellular tail.
The extracellular region contains two domains homolo-
gous to the type A cysteine-rich repeats found in the low-
density lipoprotein receptor (LDL-R) family and several
other proteins, including the terminal complement compo-
nents such as C8 and C9 (23, 24). Each domain of the 8D6
Ag contains both the six cysteines and the acidic residues
between the fifth and sixth cysteines that are characteristic
of this domain (Fig. 3
 
 
 
B). The three-dimensional structure
of one domain of the human LDL-R has been determined
by nuclear magnetic resonance spectroscopy and has been
Figure 2. mAb 8D6 inhibits
FDC–B cell interaction. (A)
Tonsillar B cells were cocultured
with irradiated FDC clusters
(2,000 clusters per well; 5,000
rads) for 10 d in the presence of
mAb 8D6 or 3C8, anti-CD40
(100 ng/ml), rhIL-2 (10 U/ml),
and rhIL-10 (30 ng/ml). IgG
levels in conditioned media were
measured by human IgG–spe-
cific ELISA. IgG concentrations
in the control cultures with B
cells and B cells plus FDCs were
0.26 and 1.8 mg/ml, respec-
tively. (B and C) GC B cells
were cocultured with or without
mAb 8D6 in the presence of irra-
diated HK cells, CD40L, rhIL-2,
and rhIL-10. Results of viable
cell recovery (B, left), IgG secre-
tion (B, right), and cell cycle
progression (C) are shown.
Figure 3. (A and B) Expression cloning of the 8D6 Ag cDNA. (A) An HK cell cDNA expression library was screened by in situ staining of transiently
transfected COS cells with the mAb 8D6. A cDNA clone encoding the 8D6 Ag was isolated, and its predicted amino acid sequence is shown. The nu-
cleotide sequence was deposited with EMBL/GenBank/DDBJ (sequence data available under accession no. AF161254). A putative signal sequence
cleavage site is indicated with an arrowhead, and a predicted transmembrane domain is underlined. Three consensus sites for N-linked glycosylation are
each marked with an asterisk. Each cysteine residue is highlighted with dark shading, and the two regions homologous to the LDL-R type A domain are
shown in light shaded boxes. (B) The two regions homologous to the LDL-R (LDLR) type A domain, named the 8D6 Ag A (8D6-A, residues 54–89)
and the 8D6 Ag B (8D6-B, residues 132–167) domains are shown aligned to the NH2-terminal type A domain of the human LDL-R and the human
complement C9 protein. Identical residues are shown in dark background, and conserved residues in light background. (C–E) 8D6 Ag cDNA–trans-
fected COS cells stimulate B cell proliferation and differentiation. Mock (COSMock)or 8D6 Ag cDNA (COS8D6)-transfected COS cell–B cell cocultures
were performed. The viable cell number of B cells (C) and IgG secretion data (D) was shown. In blocking experiments, transfected COS cells were
treated with mAb 8D6 for 30 min at 378C before coculture with B cells (E). 
1081
 
Li et al. Brief Definitive Report
 
found to consist of a 
 
b
 
 hairpin followed by a series of 
 
b
 
turns, with the majority of the acidic residues on one side
of the structure (25). The two domains of the 8D6 Ag are
separated by an additional cysteine-rich region interrupted
by a stretch of four proline residues. There is a consensus
site for 
 
N
 
-glycosylation in this spacer region and two addi-
tional sites located between the second LDL-R type A do-
main and the putative transmembrane domain.
The similarity of the 8D6 Ag cysteine-rich type A do-
mains to homologous sequences was further examined
using the GAP program with the blosum62 matrix
(www.gcg.com; Fig. 3 B). The first cysteine-rich domain
of the 8D6 Ag (8D6A) has 62% similarity (50% identity) to
the domain of human C9, and 54% similarity (49% iden-
tity) to that of the NH
 
2
 
-terminal domain of the human
LDL-R. The second cysteine-rich domain of the 8D6 Ag
(8D6B) has 44% similarity (38% identity) to the C9 do-
main, and 46% similarity (43% identity) to that of the LDL-R.
The homology of the 8D6 Ag with the LDL-R family was
limited to these domains.
The LDL-R has been intensively investigated because its
malfunction causes atherosclerosis (26). The LDL-R is es-
sential to transport LDL out of plasma into the tissues. Re-
cently, it has become clear that most of the LDL-R super-
family does not have a primary function in LDL import,
but binds multiple ligands in motility and adhesions of neu-
rons (27). For example, very low-density lipoprotein re-
ceptor (VLDL-R) is involved in neuron traffic in brain
development, as demonstrated recently in VLDL-R
knockout mice (28). It is intriguing to find that the 8D6
molecule shares a significant homology with LDL-R.
Hence, it is important to investigate whether the 8D6 mol-
 
ecule expressed in the GC is involved in attracting Ag-acti-
vated B cells to expand in the initial interaction stage of
FDC B cells. This hypothesis can be studied in the 8D6
gene-targeted mice.
Similar to the broad expression of LDL-R genes in tis-
sues, 8D6 Ag gene is expressed in many tissues, as 8D6
mRNA was detected in most human tissues by Northern
blot (data not shown). As 8D6 Ag is expressed abundantly
in FDCs in the GC (Fig. 1), the mAb 8D6 may recognize
the functionally important epitope of the 8D6 protein in-
volved in FDC–B cell interaction in the GC.
 
Recombinant 8D6 Ag Enhances B Cell Growth. 
 
The func-
tional activity of 8D6 Ag in B cell costimulation was analyzed
in vitro by using transfected COS cells. In the cocultures with
anti-CD40–activated B cells, the 8D6 Ag–transfected COS
cells enhanced B cell proliferation (Fig. 3 C) and differentia-
tion by inducing IgG secretion (Fig. 3 D) two to seven
times higher than the mock-transfected COS cells. In addi-
tion, this activity was specifically blocked by mAb 8D6
(Fig. 3 E), but not by the control Ab with the same isotype.
Thus, the 8D6 Ag expressed by COS cells was able to pro-
vide a specific costimulatory signal in augmenting growth
and differentiation of GC B cells.
 
The Growth Inhibition of Lymphoma Cell Line, L3055, by
mAb 8D6. 
 
GC B cells undergo complex interactions
with FDCs and T cells in the course of differentiation into
memory B and plasma cells. GC B cells freshly isolated
from tonsils are heterogeneous regarding the stage of differ-
entiation, mutation frequency, and Ig class (29). They may
not be ideal for characterizing the external signals operating
at each stage of B cell growth and differentiation in the
GC. A monoclonal population of dividing cells would be
Figure 4. mAb 8D6 inhibits HK-depen-
dent L3055 cell proliferation. (A and B)
HK-dependent L3055 cells (2 3 104 cells/
ml) were cultured in the presence of irradi-
ated HK or CD32-transfected L cells (2 3
104 cells per well; 5,000 rads) for the indi-
cated time periods in 24-well plates (A). In a
separate experiment, L3055 cells were cul-
tured with or without mAb 8D6 or 3C8 in
the presence of irradiated HK cells for 5 d
(B). Viable cells were counted by trypan
blue exclusion assay, and viable cell recov-
ery percentages are shown. According to a
Student’s t test, the differences between the
treatments with mAbs 8D6 or 3C8 were
statistically significant (P , 0.05), and the
differences between the treatment with
mAb 3C8 and no treatment were not signif-
icant (P . 0.05). (C) L3055 cells (104 cells/
ml) were cultured in the presence or ab-
sence of irradiated HK cells for 24 h. HK
cells were pretreated with mAbs 8D6 or
3C8 for blocking experiments. Cultured
cells were stained with FITC-labeled an-
nexin V and propidium iodide. 
1082
 
FDC Signaling Molecule
 
devoid of the problems of freshly isolated GC B cells. To
delineate the individual roles of FDCs and T cells in GC B
cell differentiation at the clonal level and to analyze the sig-
nals involved, we adopted a unique experimental model
using an FDC line, HK, and a lymphoma cell line, L3055,
that resembles centroblasts (13). A detailed phenotypic
analysis revealed L3055 cells to be a clonal population orig-
inating from the GC. Like freshly isolated centroblasts,
L3055 cells underwent spontaneous apoptosis when cul-
tured in the absence of fresh FDCs or HK cells. L3055 cells
proliferated continuously in the presence of HK cells (Fig.
4 A), whereas they differentiated into a population with the
phenotype of centrocytes after stimulation with CD40L
and IL-4 (13). The experimental results demonstrate a dis-
tinct function of FDCs, in that FDCs provide signals for
rapid proliferation of centroblasts, whereas T cells confer
signals for differentiation of centroblasts into centrocytes. T
cells collaborate with FDCs in the protection and expan-
sion of the Ag-specific GC B cells. The L3055 growth-
supporting activity of HK cells cannot be replaced by
CD32-transfected L cells, and therefore is presumably not a
nonspecific feeder cell effect (Fig. 4 A). In addition, the ap-
parent activity of HK cells in this coculture is decreased by
the addition of the mAb 8D6, but not of isotype control
3C8 (Fig. 4 B). These results suggest that 8D6 Ag may be an
important factor for the growth of lymphoma cells originat-
ing in the GC. The inhibition by mAb 8D6 alone is not
complete, suggesting the presence of other growth factors.
The growth inhibition by mAb 8D6 could result either
from the apoptosis of L3055 cells or from neutralizing a
growth factor. To determine whether mAb 8D6 affected
apoptosis, we analyzed the effect of mAb 8D6 on apoptosis
by labeling the cells with annexin V and propidium iodide.
As shown in Fig. 4 C, mAb 8D6 did not interfere with the
capacity of HK cells to prevent spontaneous apoptosis. This
result suggests that the 8D6 Ag molecule is not an antiapop-
tosis factor. Taken together, these results strongly suggest
that 8D6 Ag is a novel membrane molecule of FDCs that
augments proliferation of B cells in the GC.
In the early stage, follicular lymphoma, one of the most
common hematological malignancies in adults, is usually
indolent, regressing spontaneously and showing susceptibil-
ity to chemotherapy (30). However, this tumor usually re-
curs and can undergo blast transformation to an aggressive
form, ultimately becoming a fatal disease. The generation
and blast transformation of this tumor occurs in close asso-
ciation with FDCs in the GC (31). We have demonstrated
that the in vitro growth of L3055 can be blocked by mAb
against the 8D6 Ag. Thus, this molecule deserves consider-
ation as a critical signal in the early stage of lymphomagen-
esis. If our observation in vitro extrapolates to the in vivo
growth of such tumors, antagonists of the 8D6 Ag signaling
pathway may be of value in countering the growth of folli-
cular lymphomas or other tumors that metastasize to the
lymphoid follicles.
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